BMC CANCER Journal
Overview
publication venue for
- Patterns and trends in melanoma mortality in the United States, 1999-2020. 24. 2024
- TP53 mutation prevalence in normal airway epithelium as a biomarker for lung cancer risk. 23. 2023
- PARP inhibitors chemopotentiate and synergize with cisplatin to inhibit bladder cancer cell survival and tumor growth. 22. 2022
- Technical advance in targeted NGS analysis enables identification of lung cancer risk-associated low frequency TP53, PIK3CA, and BRAF mutations in airway epithelial cells. 19. 2019
- The JNK signaling pathway plays a key role in methuosis (non-apoptotic cell death) induced by MOMIPP in glioblastoma. 19. 2019
- A lung cancer risk classifier comprising genome maintenance genes measured in normal bronchial epithelial cells. 17. 2017
- CEBPG transcription factor correlates with antioxidant and DNA repair genes in normal bronchial epithelial cells but not in individuals with bronchogenic carcinoma. 5:141. 2005
- Homologous recombination proficiency in ovarian and breast cancer patients 2021
- Infection risks in multiple myeloma: a systematic review and meta-analysis of randomized trials from 2015 to 2019 2021
- Similar response rates and survival with PARP inhibitors for patients with solid tumors harboring somatic versus Germline BRCA mutations: a Meta-analysis and systematic review 2020
Research
category
- ONCOLOGY Category
Identity
International Standard Serial Number (ISSN)
- 1471-2407
Electronic International Standard Serial Number (EISSN)
- 1471-2407
Other
journal abbreviation
- BMC CANCER